Rhumbline Advisers Buys 7,408 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
Rhumbline Advisers grew its position in shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Free Report) by 4.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 180,964 shares of the company’s stock after purchasing an additional 7,408 shares during the quarter. Rhumbline Advisers’ […]
Rhumbline Advisers grew its position in shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Free Report) by 4.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 180,964 shares of the company’s stock after purchasing an additional 7,408 shares during the quarter. Rhumbline Advisers’ […]
